Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Excepgen
AddedFeb 16, 2024
UpdatedJun 18, 2026
Excepgen

Excepgen

Seed

ExcepGen: A San Francisco-based biotech firm innovating in drug discovery for next-gen therapeutics.

HQ
San Francisco, CA, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorW19
Overview
Compare
Fundraising
Employees
Website

ExcepGen, founded in San Francisco, is an early-stage biotechnology company dedicated to revolutionizing drug discovery. The company's core mission is to address fundamental challenges in the field and develop next-generation therapeutics. ExcepGen specializes in nucleic acid medicines, including gene therapies and vaccines powered by innovative DNA and mRNA technologies. Their market focus is on creating advanced solutions for unmet medical needs, leveraging cutting-edge scientific advancements to improve patient outcomes.

ExcepGen has garnered attention from notable investors and industry leaders due to its pioneering approach in biotechnology. The company has achieved significant milestones in nucleic acid therapeutics, particularly in enhancing the capping, delivery, and manufacturing processes of DNA and mRNA. These advancements have positioned ExcepGen as a key player in the biotech industry, contributing to the development of more effective and targeted treatments. The impact of their work is evident in the potential to transform therapeutic practices and improve global health outcomes.

Excepgen - Similar Companies

Exegenesis Bio logo

Exegenesis Bio

exegenesisbio.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Engage Bio logo

Engage Bio

Exotech Bio logo

Exotech Bio

IgGenix logo

IgGenix

iggenix.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

NExTNet logo

NExTNet

nextnetinc.com

Amber Bio logo

Amber Bio

amber.bio

Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

entelexo.com

Revagenix logo

Revagenix

revagenix.com

GenEdit logo

GenEdit

genedit.com

NabGen logo

NabGen

nabgen.com

Strm.Bio logo

Strm.Bio

strm.bio

Anagenex logo

Anagenex

anagenex.com

Sixfold Bioscience logo

Sixfold Bioscience

sixfold.bio

Excepgen - Quick Facts

Who are Excepgen's competitors?

Companies similar to Excepgen include Exegenesis Bio, Excision BioTherapeutics, Engage Bio and Exotech Bio.

When was Excepgen founded?

Excepgen was founded in 2018.

Where is Excepgen's headquarters located?

Excepgen's headquarters is located in San Francisco, CA, US.

When was Excepgen's last funding round?

Excepgen's most recent funding round was for $4M (USD) in August 2023.

How much has Excepgen raised to-date?

As of Aug 24, 2023, Excepgen has raised a total of $4.2M (USD).

How many employees does Excepgen have?

Excepgen has 6 employees as of Feb 4, 2024.

Excepgen - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapies
  • Vaccines
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified